Home › Pancreatic Cancer › Connecticut › New Haven
Pancreatic Cancer clinical trials in New Haven, CT
16 studies for Pancreatic Cancer are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
- Yale Cancer Center, New Haven
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecruitingPhase 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RecruitingPhase 3
- Yale University, New Haven
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
RecruitingPhase 1/2
- Yale University Cancer Center LAO, New Haven
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RecruitingPhase 1
- Yale Cancer Center, New Haven
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecruitingObservational study
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale-New Haven Hospital Saint Raphael Campus, New Haven
- Yale University, New Haven
- and 6 more
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RecruitingPhase 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital-Hamden Care Center, Hamden · 6 mi away
- and 3 more
Pancreatic Cancer Early Detection Consortium
RecruitingObservational studyHealthy volunteers welcome
- Yale University, New Haven
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
RecruitingPhase 1/2
- Yale University, New Haven
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecruitingPhase 1
- Smilow Cancer Hospital (Yale University), New Haven
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
RecruitingObservational studyHealthy volunteers welcome
- Yale University, New Haven
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecruitingPhase 2
- Ohio State University-Telemedicine, New Haven
The Cancer of the Pancreas Screening-5 CAPS5)Study
RecruitingPhase 3
- Yale University, New Haven
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
RecruitingObservational study
- Yale School of Medicine, New Haven
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
RecruitingPhase 2/3
- Yale Cancer Center, New Haven
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.